| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:414-421.)
© 2006 American Heart Association, Inc.
Molecular Cardiology |
From the Departments of Intensive Care Medicine (P.P., M.J.D., M.P.W.J.M.B., J.G.v.d.H.) and Pharmacology-Toxicology (P.S.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Correspondence to P. Pickkers, Department of Intensive Care Medicine (551), Radboud University Nijmegen Medical Centre, GeertGrooteplein 10, PO Box 9101, 6500HB, Nijmegen, Netherlands. E-mail p.pickkers{at}ic.umcn.nl
Received September 22, 2005; revision received May 5, 2006; accepted May 26, 2006.
Background During septic shock, the vasoconstrictor response to norepinephrine is seriously blunted. Animal experiments suggest that hyperpolarization of smooth muscle cells by opening of potassium (K) channels underlies this phenomenon. In the present study, we examined whether K-channel blockers and/or nitric oxide (NO) synthase inhibition could restore norepinephrine sensitivity during experimental human endotoxemia.
Methods and Results Volunteers received 2 ng/kg Escherichia coli endotoxin intravenously. Forearm blood flow (FBF) was measured with venous occlusion plethysmography. Infusion of 4 dose steps of norepinephrine into the brachial artery decreased the FBF ratio (ratio of FBF in the experimental arm to FBF in the control arm) to 84±4%, 70±4%, 55±4%, and 38±4% (mean±SEM) of its baseline value. After endotoxin administration, norepinephrine-induced vasoconstriction was attenuated (FBF ratio, 101±4%, 92±4%, 83±6%, and 56±7%; n=30; P=0.0018; pooled data). Intrabrachial infusion of the K-channel blocker tetraethylammonium (TEA) completely restored the vasoconstrictor response to norepinephrine from 104±5%, 93±7%, 93±12%, and 69±12% to 89±9%, 73±4%, 59±5%, and 46±8% (n=6; P=0.045). Other K-channel blockers did not affect the response to norepinephrine. The NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA; 0.2 mg · min1 · dL1 intra-arterially) also restored the norepinephrine sensitivity. In the presence of L-NMMA, TEA did not have an additional effect on the norepinephrine-induced vasoconstriction (n=6; P=0.9).
Conclusions The K-channel blocker TEA restores the attenuated vasoconstrictor response to norepinephrine during experimental human endotoxemia. Coadministration of L-NMMA abolishes this potentiating effect of TEA, suggesting that NO mediates the endotoxin-induced effect on vascular K channels. In the absence of an effect of the selective adenosine triphosphatedependent K-channel blocker tolbutamide, we conclude that the blunting effect of endotoxin on norepinephrine-induced vasoconstriction is caused by NO-mediated activation of calcium-activated K channels in the vascular wall.
This article has been cited by other articles:
![]() |
P. Nardi, A. Pellegrino, A. Scafuri, D. Colella, C. Bassano, P. Polisca, and L. Chiariello Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction. Ann. Thorac. Surg., May 1, 2009; 87(5): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Leithead, J W Ferguson, C M Bates, J S Davidson, A Lee, A J Bathgate, P C Hayes, and K J Simpson The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure Gut, March 1, 2009; 58(3): 443 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sayk, A. Vietheer, B. Schaaf, P. Wellhoener, G. Weitz, H. Lehnert, and C. Dodt Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R891 - R898. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Clapp and N. N. Orie Stoking Up BKCa Channels in Hemorrhagic Shock: Which Channel Subunit Is Really Fueling the Fire? Circ. Res., August 31, 2007; 101(5): 436 - 438. [Full Text] [PDF] |
||||
![]() |
E. H.J.M. Kemna, H. Tjalsma, V. N. Podust, and D. W. Swinkels Mass Spectrometry-Based Hepcidin Measurements in Serum and Urine: Analytical Aspects and Clinical Implications Clin. Chem., April 1, 2007; 53(4): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |